The Role of the RAC in the Peer Review of CVM’s Risk Assessments Barry Hooberman, Ph.D., MPH Center for Veterinary Medicine Office of New Animal Drug Evaluation.

Slides:



Advertisements
Similar presentations
ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
Advertisements

Geneva, Switzerland, June 2000
Phytosanitary Risk Analysis – the New Zealand Experience
Putting Principles into Practice: Useful Case Studies th Street, N.W., Suite 750, Washington, DC, 20005, USA
Wrap-Up and Potential Future Actions Mary J. Bartholomew, Mathematical Statistician Center for Veterinary Medicine Center for Veterinary Medicine at the.
What We Heard and Next Steps. The people who made this possible Wes Long Audrey Ichida Sharon Thompson Mary Bender Steve Schaub Sherri Dennis Wendy Fineblum.
Steven D. Vaughn, DVM Director Office of New Animal Drug Evaluation Center for Veterinary Medicine U. S. Food and Drug Administration June 6, 2012 Embracing.
EFSA’s Mission and Priorities Bernhard Berger Head of the Advisory Forum and Scientific Cooperation Unit Conference “Importance of food additives today.
International Agency for Research on Cancer (IARC) Classification of Radio Frequency (RF) Summary – May 2011.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
CFSAN’s Peer Review for Risk Assessments Robert L. Buchanan, Sherri Dennis, and Marianne Miliotis.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
Food Safety Microbiology - February, of 27 Quantitative Risk Assessment Don Schaffner, Ph.D. Rutgers, The State University of NJ.
Erik P. Mettler, M.P.A., M.P.H. Associate Commissioner for Food and Veterinary Medicine September 29, 2014.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Background, Introduction, Statutory Authority, Introduction to Risk-Based Approach Larisa Rudenko, PhD, DABT.
FAO/WHO CODEX TRAINING PACKAGE
Animal Feed GRAS Notifications Geoffrey K. Wong, M.S. Division of Animal Feeds Center for Veterinary Medicine Pet Food Institute Pet Food Institute October.
Malini M. Wileman, PhD, RAC Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Regulation of.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
June 16-19, USEPA Cancer Guidelines: Mode of Carcinogenic Action 1 ICABR – Impacts of the Bioeconomy on Agricultural Sustainability, the Environment.
Preventive Controls Phase 2 Workgroup 1.
1 Thailand Researches in Microbiological Risk Assessment : Past & Present Suphachai Nuanualsuwa n DVM, MPVM, PhD.
Predicting human dose-response relationships from multiple biological models: Issues with Cryptosporidium parvum Risk Assessment Consortium.
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Antibiotic Resistance: Animals, people, and bacteria
Risk Assessment: Food Safety and Public Health Hazards Karen Carson Deputy Director Office of Plant and Dairy Foods and Beverages.
Managing food chain risks: the role of uncertainty Richard Shepherd University of Surrey.
Science - the basis of CODEX work. The Role of Science in Codex Decision-Making Key principles Risk analysis guide Codex stds from development to implementation.
FSIS’s Needs for Peer Review of Risk Assessments Carol Maczka, Ph.D. Senior Scientist for Risk Assessment FSIS/USDA September 30, 2003 Presented at JIFSAN/SRA/RAC.
Terezia Sinkova EFSA The new EU Food Safety Agency.
Relating Food Animal and Human Antimicrobial Use Comments to the FDA Anti-Infective Drugs Advisory Committee on behalf of the on behalf of the American.
SMMSS - Support to Modernisation of Mongolia Standardisation System Food Chain Risk Assessment and Management - Seminar on Food Safety Ulaanbaatar / Mongolia.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Multimedia Assessment for New Fuels: Stakeholders’ Meeting September 13, 2005 Sacramento, CA Dean Simeroth, California Air Resources Board Dave Rice, Lawrence.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
Introduction to GMOs: Myths and realities Masami Takeuchi, Ph.D. Food Safety Officer.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
RISK MANAGEMENT The process of weighing policy alternatives in the light of the results of risk assessment and, if required, selecting and implementing.
Risk Assessments: Models for Estimating the Risk of Transmitting TSE by Human Tissue Intended for Transplantation Rolf E. Taffs, Ph.D. Center for Biologics.
Major Components of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Non-O157 STEC: New Challenges / Practical Limitations / Next Steps Robert L. Buchanan HHS Food and Drug Administration Center for Food Safety and Applied.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
Risk-Based CMC Review - OGD Perspective Gary J. Buehler, R.Ph. Director Office of Generic Drugs July 21, 2004 Advisory Committee for Pharmaceutical Science.
Interagency Retail Listeria monocytogenes Risk Assessment Background, Scope, and Purpose Janell Kause Food Safety and Inspection Service June 23, 2009.
Food Safety – Challenges, Problems, and Opportunities By Thomas J. Billy, President International Food Safety Consulting, LLC Former Senior U.S. Food Safety.
Risk Assessment* and Zoonotic Implications Yvonne Nadler DVM MPH April 6, 2011 * THE FUN STUFF.
Australia’s Import Risk Analysis Process Compared and Contrasted Mary Harwood Executive Manager Biosecurity Australia.
Role of Economics in Pathogen Control Regulations Robert L. Buchanan HHS Food and Drug Administration Center for Food Safety and Applied Nutrition.
Overview FDA Food Safety Modernization Act Section 104
HERA Second European Stakeholder Workshop July Human & Environmental Risk Assessment An A.I.S.E and CEFIC initiative on targeted risk assessment.
H azard A nalysis C ritical C ontrol P oint. HACCP : A systematic approach to the identification, evaluation, and control of food safety hazards. Hazard.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
What is Risk Assessment? Janell Kause FSIS Risk Assessment Division USDA Listeria Public Meeting February 26, 2003.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
1. Consumers, Health, Agriculture and Food Executive Agency Risk assessment with regard to food and feed safety Risk analysis Why risk assessment in the.
Fostering Antimicrobial Stewardship in Animals: Overview of FDA Activities William Flynn, DVM, MS Deputy Director for Science Policy Center for Veterinary.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Overview of the CPSC Directorate for Health Sciences * Mary Ann Danello, Ph.D. Associate Executive Director * The views expressed in this presentation.
AUDIT STAFF TRAINING WORKSHOP 13 TH – 14 TH NOVEMBER 2014, HILTON HOTEL NAIROBI AUDIT PLANNING 1.
CVM Communications Presented by Laura Alvey Deputy Director, Office of Communications Center for Veterinary Medicine Risk Communication Advisory Committee.
Plant Health Risk Assessment at EFSA
MICROBIAL RISK ANALYSIS FOR RISK MANAGERS WORKSHOP
HACCP Essential Tool for Food Safety
Quantitative Risk Assessment
Allen Chan U.S. Government Accountability Office October 2, 2018
Presentation transcript:

The Role of the RAC in the Peer Review of CVM’s Risk Assessments Barry Hooberman, Ph.D., MPH Center for Veterinary Medicine Office of New Animal Drug Evaluation Rockville, MD September 30, 2003

2 Risk Assessments at CVM Antimicrobial Resistance Human Food Safety Drug Residues Drug Residues Animal Feeds BSE BSE Contaminants (e.g., Dioxin) Contaminants (e.g., Dioxin)

3 CVM’s Needs for Peer Review Common to all Risk Assessments Independent Review Independent Review Reviewers relationship with Agency Access to sufficient data/information Access to sufficient data/information Assess scientific reliability of data Assess scientific reliability of data Transparency/Openness Transparency/Openness Much in common with CFSAN and FSIS

4 CVM’s Needs for Peer Review Distinct from CFSAN and FSIS Organization OrganizationSizeStructure Mission Mission New Drug Approvals Past Drug Approvals Subject Matter Subject Matter Antimicrobial Resistance Risk Assessment (ARRA) vs. Microbial Risk Assessment (MRA)

5 Organization of RA Activities CFSAN:CVM: Risk Analysis Team Risk Analysis Team In the process of defining the boundaries between the assessors, managers, and communicators In the process of defining the boundaries between the assessors, managers, and communicators

6 Risk Assessments and CVM’s Mission New drug approvals Guidance 152 Guidance 152 Review of past drug approvals Confidentiality restrictions may limit external peer review ARRA rely on publicly available information

7 ARRA: Different from Microbial Risk Assessment Microbial and Antimicrobial Resistance Risk Assessments for food safety overlap extensively in terms of Microbiological properties of the hazard Microbiological properties of the hazard Exposure pathways – follow the movement of bacteria in the food chain Exposure pathways – follow the movement of bacteria in the food chain Consequences – e.g., human infections Consequences – e.g., human infections Key differences: The hazardous agents are resistance determinants The hazardous agents are resistance determinants Exposure – follow the movement of resistance determinants Exposure – follow the movement of resistance determinants Two separate pathways – direct and indirect Consequences - generally requires a human intervention to translate into adverse health risks. Consequences - generally requires a human intervention to translate into adverse health risks.

8 Effects on RA Peer Review Relatively limited resources Efficient Allocation of resources for RA review Efficient Allocation of resources for RA review Regulatory considerations Use and availability of data for external review Use and availability of data for external review Use of risk assessment in the Center Use of risk assessment in the Center Different complexity of risk problem Less publicly available information on risk models Less publicly available information on risk models

9 Options for Peer Review Internal review Not independent Not independent Sufficient access to data Sufficient access to data Skills available to assess scientific reliability Skills available to assess scientific reliability Not transparent Not transparent

10 Options for Peer Review Inter-Agency review The Interagency Risk Assessment Consortium (RAC) The Interagency Risk Assessment Consortium (RAC) Semi-independent Semi-independent Potential for sufficient access to data/information Potential for sufficient access to data/information Able to assess scientific reliability Able to assess scientific reliability Not transparent, but has potential for transparency (Food Risk Clearinghouse) Not transparent, but has potential for transparency (Food Risk Clearinghouse)

11 Options for Peer Review Public Meetings/Drafts of RA Independent Independent Sufficient access to data/information Sufficient access to data/information Range of skills in assessing scientific reliability of data Range of skills in assessing scientific reliability of data Transparent Transparent

12 Options for Peer Review Outside Experts Range of independence Range of independence Used in planning, execution, and review of RAs Used solely for review Sufficient access to data/information Sufficient access to data/information Able to assess scientific reliability of data Able to assess scientific reliability of data Range of transparency Range of transparency

13 Options for Peer Review Other The Courts The CourtsIndependent Sufficient access to data/information Varying skills to assess scientific reliability of data Transparent The problem of dueling experts! Resource intensive

14 CVM’s Experiences with Peer Review Internal Review Limited capabilities Limited capabilities Inter-Agency Review RAC a very useful tool in the planning and execution of RAs RAC a very useful tool in the planning and execution of RAs RAC participation in CVM Public Meetings RAC participation in CVM Public Meetings RAC project: Practice of Microbiological Risk Assessment by U.S. Government Agencies RAC project: Practice of Microbiological Risk Assessment by U.S. Government Agencies EPA/OW funded Incorporates Agency experience that will be useful to RA peer reviewers of future microbial risk assessments

15 CVM’s Experiences with Peer Review Public Meetings/Drafts Extensively used Extensively used Wide range of comments on all aspects of risk assessment and beyond Wide range of comments on all aspects of risk assessment and beyond Consultants/Outside experts Consultants/Outside experts Consultants/Outside experts Used in all phases in risk assessments Used in all phases in risk assessments Resource-driven Resource-driven Provide independent viewpoint Provide independent viewpoint

16 CVM’s Experiences with Peer Review Lessons Learned Peer review is an important process that should be ongoing throughout the risk assessment Peer review is an important process that should be ongoing throughout the risk assessment A contentious risk assessment is independent of good peer review procedures A contentious risk assessment is independent of good peer review procedures

17 Observations/Questions Resource allocation The consumption of peer review resources is inversely proportional to the level of risk (chasing zero risk). The consumption of peer review resources is inversely proportional to the level of risk (chasing zero risk). If the risk assessment finds the risk is from zero to very- nearly-zero, should we limit/control/attenuate scarce risk management resources on extensive peer reviews? The consumption of peer review resources is proportional to the uncertainty in the estimate of risk The consumption of peer review resources is proportional to the uncertainty in the estimate of risk A highly uncertain, high risk estimate report consumes fewer peer review resources than an equivalently uncertain low risk estimate report If contentiousness and length of reviews are driven by uncertainty, then these extremes in reported risk estimates should get the same level of peer review resources

18 Observations/Questions Boundaries for determining level of Peer Review Based on magnitude (significance) of health effects, costs/benefits of risk management actions? Based on magnitude (significance) of health effects, costs/benefits of risk management actions? Use of outside experts in RA and peer review Questions of independence Questions of independence Relationship to Agency and regulated industry

19 Acknowledgements H. Gregg Claycamp Mary Bartholomew